Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0005
0.0000
(0.00%)
At close: February 28 at 3:00:00 PM EST
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Expense
1,015.8220
1,420.5090
1,672.2810
1,868.7340
2,001.6170
Operating Income
-1,015.8220
-1,420.5090
-1,672.2810
-1,868.7340
-2,001.6170
Net Non Operating Interest Income Expense
-199.0440
-218.9730
-178.6520
-474.7680
-1,285.4600
Other Income Expense
--
277.8050
-2,274.2610
2,196.9740
-45.7730
Pretax Income
-1,129.8670
-1,361.6770
-4,125.1940
-146.5280
-3,332.8500
Net Income Common Stockholders
-1,142.4260
-1,639.9920
-4,125.1940
-530.8730
-3,725.0270
Diluted NI Available to Com Stockholders
-1,142.4260
-1,639.9920
-4,125.1940
-530.8730
-3,725.0270
Basic EPS
-0.00
-0.00
-0.01
-0.00
-0.01
Diluted EPS
-0.00
-0.00
-0.01
-0.00
-0.01
Basic Average Shares
405,589.6820
396,728.6800
357,721.1890
317,621.9420
285,190.7290
Diluted Average Shares
405,589.6820
396,728.6800
357,721.1890
317,621.9420
285,190.7290
Total Operating Income as Reported
-1,015.8220
-1,420.5090
-1,672.2810
-1,868.7340
-2,001.6170
Total Expenses
1,015.8220
1,420.5090
1,672.2810
1,868.7340
2,001.6170
Net Income from Continuing & Discontinued Operation
-1,129.8670
-1,361.6770
-4,125.1940
-530.8730
-3,725.0270
Normalized Income
-1,129.8660
-1,319.4820
-1,750.9330
-2,295.1185
-3,514.6630
Interest Expense
199.0440
218.9730
178.6520
474.7680
1,285.4600
Net Interest Income
-199.0440
-218.9730
-178.6520
-474.7680
-1,285.4600
EBIT
-930.8230
-1,142.7040
-3,946.5420
328.2400
-2,047.3900
EBITDA
-930.8230
-1,142.0800
-3,884.8820
398.7280
-2,000.0370
Reconciled Depreciation
--
0.6240
61.6600
70.4880
47.3530
Net Income from Continuing Operation Net Minority Interest
-1,129.8670
-1,361.6770
-4,125.1940
-146.5280
-3,332.8500
Total Unusual Items Excluding Goodwill
-0.0010
-42.1950
-2,374.2610
2,187.9740
181.8130
Total Unusual Items
-0.0010
-42.1950
-2,374.2610
2,187.9740
181.8130
Normalized EBITDA
-930.8220
-1,099.8850
-1,510.6210
-1,789.2460
-2,181.8500
Tax Rate for Calcs
--
--
--
0
--
Tax Effect of Unusual Items
--
--
--
39.3835
--
3/31/2021 - 12/29/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CNBX CNBX Pharmaceuticals Inc.
0.0100
0.00%
CARA Cara Therapeutics, Inc.
4.7800
-1.04%
ADAP Adaptimmune Therapeutics plc
0.5400
-2.01%
NTRB Nutriband Inc.
7.27
+0.83%
SLRX Salarius Pharmaceuticals, Inc.
1.0800
-12.20%
CERO CERo Therapeutics Holdings, Inc.
1.6700
+3.73%
BLRX BioLineRx Ltd.
3.3500
+1.82%
CCCC C4 Therapeutics, Inc.
2.7100
+4.23%
CLDI Calidi Biotherapeutics, Inc.
0.8795
+5.56%
CDT Conduit Pharmaceuticals Inc.
1.2000
+7.14%